Example: Heart Attack

Search clinical trials for: Alogliptin

Total 73 results

NCT03042325

Withdrawn

Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT02221284

Completed

Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"

Conditions: Type 2 Diabetes Mellitus
NCT01964963

Completed

Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT01990300

Completed

Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT01945216

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

Conditions: Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution
NCT02856113

Recruiting

Phase 3 Alogliptin Pediatric Study

Conditions: Diabetes Mellitus, Type 2
NCT02756832

Completed

An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

Conditions: Diabetes Mellitus
NCT00957268

Completed

Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT03555565

Completed

Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"

Conditions: Type 2 Diabetes Mellitus
NCT00306384

Completed

Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus
NCT00968708

Completed

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Conditions: Diabetes Mellitus, Type 2; Acute Coronary Syndrome
NCT01456130

Completed

Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes

Conditions: Diabetes Mellitus
NCT01945242

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

Conditions: Type 2 Diabetes Melitus
NCT01521962

Completed

Study of Combination Therapy With SYR-322

Conditions: Diabetes Mellitus
NCT01391663

Completed

Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants

Conditions: Pharmacokinetics and Pharmacodynamics
NCT01318122

Completed

Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

Conditions: Type 2 Diabetes Mellitus
NCT02771093

Completed

An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT03499704

Recruiting

A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy

Conditions: Diabetes Mellitus, Type 2
NCT02989649

Terminated

Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

Conditions: Diabetes Mellitus, Type 2
NCT01303055

Unknown status

Effects of Alogliptin on Pancreatic Beta Cell Function

Conditions: Diabetes Mellitus, Type 2
NCT01263509

Completed

Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

Conditions: Type 2 Diabetes Mellitus
NCT00707993

Completed

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

Conditions: Diabetes Mellitus
NCT02231021

Completed

The Practical Evidence of Antidiabetic Combination Therapy in Korea

Conditions: Type 2 Diabetes Mellitus
NCT02798172

Completed

The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Conditions: Diabetes Mellitus, Type 2
NCT00286455

Completed

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

Conditions: Diabetes Mellitus